NervGen Pharma Corp. (TSXV:NGEN)
Canada flag Canada · Delayed Price · Currency is CAD
2.980
+0.010 (0.34%)
Apr 29, 2025, 12:17 PM EDT

NervGen Pharma Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-24.01-22.38-20.72-12.73-11.19
Upgrade
Depreciation & Amortization
0.080.150.120.040.04
Upgrade
Loss (Gain) From Sale of Assets
0.01----
Upgrade
Stock-Based Compensation
5.86.042.774.023.42
Upgrade
Other Operating Activities
0.445.14-2.07-0.030.02
Upgrade
Change in Accounts Receivable
-0.17-0.220.04-00.06
Upgrade
Change in Accounts Payable
1.23-0.072.320.32-0.17
Upgrade
Change in Other Net Operating Assets
-0.220.06-0.240.111.52
Upgrade
Operating Cash Flow
-16.84-11.3-17.78-8.27-6.3
Upgrade
Capital Expenditures
--0.01-0.02-0-0
Upgrade
Sale of Property, Plant & Equipment
-0---
Upgrade
Sale (Purchase) of Intangibles
--0.14--0.04-
Upgrade
Other Investing Activities
0.06----
Upgrade
Investing Cash Flow
0.06-0.14-0.02-0.05-0
Upgrade
Long-Term Debt Repaid
-0.1-0.1-0.08--
Upgrade
Net Debt Issued (Repaid)
-0.1-0.1-0.08--
Upgrade
Issuance of Common Stock
24.430.8722.8521.289.02
Upgrade
Other Financing Activities
-1.63--0.13-1.67-1.17
Upgrade
Financing Cash Flow
22.70.7722.6419.617.85
Upgrade
Foreign Exchange Rate Adjustments
-0.31-0.120.690.03-0.05
Upgrade
Net Cash Flow
5.61-10.795.5211.331.5
Upgrade
Free Cash Flow
-16.84-11.3-17.81-8.27-6.3
Upgrade
Free Cash Flow Per Share
-0.25-0.19-0.34-0.21-0.20
Upgrade
Levered Free Cash Flow
-8.84-0.3-3-3.56-2.17
Upgrade
Unlevered Free Cash Flow
-8.84-0.3-2.67-3.56-2.17
Upgrade
Change in Net Working Capital
-0.87-4.76-8.85-0.43-1.38
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.